40770 Federal Register / Vol. 83, No. 159 / Thursday, August 16, 2018 / Notices 

1A selected borrowing from a non-exempt entity 

is an unsecured borrowing (an unsecured primary 

obligation undertaken by the reporting institution 

as a means of obtaining funds) in U.S. dollars from 

a counterparty that is a non-exempt entity as 

derived from Regulation D, Section 204.2(a)(vii). 

The annual burden for this 

information collection is estimated to be 

7,806 hours. This represents an increase 

of 5,472 hours from the current burden 

estimate of 2,334 hours. This increase is 

not due to any new requirements 

imposed by the FDIC. Rather, it is due 

to FDIC’s reassessment of the burden 

hours associated with the contracting 

process and to better account for the 

burdens associated with requests for 

proposals and price quotations as well 

as RFIs. 

Request for Comment 

Comments are invited on: (a) Whether 

the collection of information is 

necessary for the proper performance of 

the FDIC’s functions, including whether 

the information has practical utility; (b) 

the accuracy of the estimates of the 

burden of the information collection, 

including the validity of the 

methodology and assumptions used; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. All comments will become 

a matter of public record. 

Dated at Washington, DC, on August 13, 

2018. 

Federal Deposit Insurance Corporation. 

Robert E. Feldman, 

Executive Secretary. 

[FR Doc. 2018–17647 Filed 8–15–18; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Agency Information Collection 

Activities: Announcement of Board 

Approval Under Delegated Authority 

and Submission to OMB 

AGENCY: Board of Governors of the 

Federal Reserve System. 

SUMMARY: The Board of Governors of the 

Federal Reserve System (Board) is 

adopting a proposal to extend for three 

years, with revision, the Report of 

Selected Money Market Rates (FR 2420; 

OMB No. 7100–0357). The revisions are 

applicable as of October 1, 2018. 

FOR FURTHER INFORMATION CONTACT: 

Federal Reserve Board Clearance 

Officer—Nuha Elmaghrabi—Office of 

the Chief Data Officer, Board of 

Governors of the Federal Reserve 

System, Washington, DC 20551 (202) 

452–3829. Telecommunications Device 

for the Deaf (TDD) users may contact 

(202) 263–4869, Board of Governors of 

the Federal Reserve System, 

Washington, DC 20551. 

OMB Desk Officer—Shagufta 

Ahmed—Office of Information and 

Regulatory Affairs, Office of 

Management and Budget, New 

Executive Office Building, Room 10235, 

725 17th Street NW, Washington, DC 

20503 or by fax to (202) 395–6974. 

SUPPLEMENTARY INFORMATION: On June 

15, 1984, the Office of Management and 

Budget (OMB) delegated to the Board 

authority under the Paperwork 

Reduction Act (PRA) to approve of and 

assign OMB control numbers to 

collection of information requests and 

requirements conducted or sponsored 

by the Board. Board-approved 

collections of information are 

incorporated into the official OMB 

inventory of currently approved 

collections of information. Copies of the 

Paperwork Reduction Act Submission, 

supporting statements and approved 

collection of information instrument(s) 

are placed into OMB’s public docket 

files. The Board may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

Final approval under OMB delegated 

authority of the extension for three 

years, with revision, of the following 

report: 

Report title: Report of Selected Money 

Market Rates. 

Agency form number: FR 2420. 

OMB control number: 7100–0357. 

Effective Date: October 1, 2018. 

Frequency: Daily. 

Respondents: Commercial banks, 

savings associations, U.S. branches and 

agencies of foreign banks, International 

Banking Facilities, and significant 

banking organizations representing 

entities actively participating in the 

federal funds and/or other money 

markets. 

Estimated number of respondents: 99 

commercial banks and savings 

associations, 84 U.S. branches and 

agencies of foreign banks, 82 

International Banking Facilities, and 1 

significant banking organization. 

Estimated average hours per response: 

1.8 commercial banks and savings 

associations, 1.8 U.S. branches and 

agencies of foreign banks, 1.0 

International Banking Facilities, and 1.8 

significant banking organization. 

Estimated annual burden hours: 

44,550 commercial banks and savings 

associations, 37,800 U.S. branches and 

agencies of foreign banks, 20,500 

International Banking Facilities, and 

450 significant banking organization. 

General description of report: The FR 

2420 is a transaction-based report that 

collects daily liability data on federal 

funds purchased, selected borrowings 

from non-exempt entities, Eurodollar 

transactions, and time deposits and 

certificates of deposits (CDs) from (1) 

domestically chartered commercial 

banks and savings associations that have 

$18 billion or more in total assets as 

well as those that have total assets above 

$5 billion but less than $18 billion and 

meet the activity threshold, (2) U.S. 

branches and agencies of foreign banks 

with total third-party assets of $2.5 

billion or more, and (3) significant 

banking organizations that are active 

participants in money markets.1 The FR 

2420 also collects daily data on 

Eurodollar transactions from 

International Banking Facilities (IBFs) of 

the above-referenced institutions. The 

FR 2420 data are used in the publication 

of the effective federal funds rate (EFFR) 

and overnight bank funding rate (OBFR) 

and in analysis of current money market 

conditions. 

Legal authorization and 

confidentiality: The FR 2420 is 

authorized by section 11(a)(2) of the 

Federal Reserve Act, which authorizes 

the Board to require depository 

institutions to make such reports of 

their liabilities and assets as the Board 

may determine to be necessary or 

desirable to enable the Board to 

discharge its responsibility to monitor 

and control monetary and credit 

aggregates (12 U.S.C. 248(a)(2)). The FR 

2420 is also authorized pursuant to 

section 7(c)(2) of the International 

Banking Act (IBA), which provides that 

Federal branches and agencies of foreign 

banks are subject to section 11(a) of the 

Federal Reserve Act as if they were a 

state member bank (12 U.S.C. 

3105(c)(2)). Section 7(c)(2) of the IBA 

also provides that state-licensed 

branches and agencies of foreign banks 

are subject to the requirement in section 

9 of the Federal Reserve Act that they 

file reports of condition with the 

appropriate Federal Reserve Bank (12 

U.S.C. 324). The obligation to comply 

with the reporting requirements of FR 

2420 is mandatory. 

The individual financial institution 

information provided by each 

respondent would not be otherwise 

available to the public. The proposed 

revisions, as well as information 

currently collected, would be accorded 

confidential treatment under the 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 159 / Thursday, August 16, 2018 / Notices 40771 

authority of exemption 4 of the Freedom 

of Information Act (5 U.S.C. 552(b)(4)). 

Exemption 4 protects from disclosure 

trade secrets and privileged or 

confidential commercial or financial 

information. 

Current actions: On May 18, 2018, the 

Board published a notice in the Federal 

Register (83 FR 23276) requesting 

public comment for 60 days on the 

extension, with revision, of the FR 2420. 

The Board proposes to revise the FR 

2420 by adding Selected Deposits (Part 

D) and removing Selected Borrowings 

from Non-Exempt Entities (Part AA). 

Other minor edits in the reporting 

instructions are proposed to improve 

clarity. The first report for the proposed 

revisions to FR 2420 would be as of 

October 1, 2018. The comment period 

for this notice expired on July 17, 2018. 

The Board received one comment from 

a government entity supporting the 

continued collection of data on the FR 

2420. The revisions will be 

implemented as proposed. 

Board of Governors of the Federal Reserve 

System, August 13, 2018. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2018–17670 Filed 8–15–18; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2018–N–2970] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Surveys and 

Interviews With Investigational New 

Drug Sponsors To Assess Current 

Communication Practices With Food 

and Drug Administration Review Staff 

Under the Sixth Authorization of the 

Prescription Drug User Fee Act 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing an opportunity for public 

comment on the proposed collection of 

certain information by the Agency. 

Under the Paperwork Reduction Act of 

1995 (PRA), Federal Agencies are 

required to publish notice in the 

Federal Register concerning each 

proposed collection of information and 

to allow 60 days for public comment in 

response to the notice. This notice 

solicits comments on a proposed 

information collection involving 

surveys and interviews of sponsors of 

commercial investigational new drugs 

(INDs) to obtain feedback about 

communication practices with FDA 

review staff. 

DATES: Submit either electronic or 

written comments on the collection of 

information by October 15, 2018. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. Electronic comments must 

be submitted on or before October 15, 

2018. The https://www.regulations.gov 

electronic filing system will accept 

comments until midnight Eastern Time 

at the end of October 15, 2018. 

Comments received by mail/hand 

delivery/courier (for written/paper 

submissions) will be considered timely 

if they are postmarked or the delivery 

service acceptance receipt is on or 

before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2018–N–2970 for ‘‘Surveys and 

Interviews with Investigational New 

Drug (IND) Sponsors to Assess Current 

Communication Practices with FDA 

Review Staff under the Sixth 

Authorization of the Prescription Drug 

User Fee Act (PDUFA VI).’’ Received 

comments, those filed in a timely 

manner (see ADDRESSES), will be placed 

in the docket and, except for those 

submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://www.gpo.gov/ 

fdsys/pkg/FR-2015-09-18/pdf/2015- 

23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852. 


sradovich on DSK3GMQ082PROD with NOTICES